Contrasting PTH Response of Denosumab Use in Dialysis Patients: A Report of 2 Cases

A common complication of end-stage renal disease (ESRD) is mineral and bone disorder. Yet, many anti-osteoporotic drugs are contraindicated in ESRD patients. Denosumab, a monoclonal antibody, does not require renal dose adjustment. However, its use is uncertain due to a lack of safety and efficacy o...

Full description

Saved in:
Bibliographic Details
Main Authors: Soo Min Jang (Author), Smitha Anam (Author), Tara Pringle (Author), Paul Lahren (Author), Sergio Infante (Author)
Format: Book
Published: MDPI AG, 2020-04-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available